Ó³»­´«Ã½

Cooper E, Posner DA, Lee CYC, et al. Childhood brain tumors instruct cranial hematopoiesis and immunotolerance. Nature genetics. 2026. doi:10.1038/s41588-025-02499-2

Schwabl P, Amaya-Romero JE, Kelley KA, et al. SIMPLseq: a high-sensitivity Plasmodium falciparum genotyping and PCR contamination tracking tool. Malaria journal. 2026. doi:10.1186/s12936-026-05796-1

Lim SH, An M, Heo YJ, et al. Distinct Spatially Resolved Tumor Microenvironment Trajectories Define Benefit from Ramucirumab plus Pembrolizumab in Refractory PD-L1+ Gastric Cancer. Cancer immunology research. 2026;14(2):307-317. doi:10.1158/2326-6066.CIR-25-0625

Pini V, Catapano F, Bonaccorso R, Weisburd B, Previtali SC, Muntoni F. Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients. Acta neuropathologica communications. 2026. doi:10.1186/s40478-026-02227-9

Tchio C, Maher M, Moth C, et al. Circadian Ser107Pro variant bridges difficulty awakening in the morning and adiposity. iScience. 2026;29(2):114587. doi:10.1016/j.isci.2025.114587

Liu E, Zhang J, Uhler C. Learning genetic perturbation effects with variational causal inference. PLoS computational biology. 2026;22(2):e1013194. doi:10.1371/journal.pcbi.1013194

Kerner G, Kamitaki N, Strober B, Price AL. Mapping disease loci to biological processes via joint pleiotropic and epigenomic partitioning. Cell genomics. 2026:101138. doi:10.1016/j.xgen.2025.101138

Rossen J, Strober BJ, Hou K, Kerner G, Price AL. Per-allele disease and complex trait effect sizes are predominantly African MAF-dependent in European populations. medRxiv : the preprint server for health sciences. 2026. doi:10.64898/2025.12.31.25343290

Garinet S, Semaan K, Li J, et al. Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma. The Journal of clinical investigation. 2026;136(3). doi:10.1172/JCI195725

Smith VL, Gidi BZ, Bragg RM, et al. Atrophin-1 antisense oligonucleotide provides robust protection from pathology in a fully humanized DRPLA model. Molecular therapy. Nucleic acids. 2026;37(1):102815. doi:10.1016/j.omtn.2025.102815